TriMas Co. (NASDAQ:TRS – Get Free Report) Director Jeffrey A. Fielkow bought 500 shares of the firm’s stock in a transaction that occurred on Monday, May 19th. The shares were acquired at an average price of $24.98 per share, with a total value of $12,490.00. Following the purchase, the director now owns 15,653 shares in the company, valued at $391,011.94. This trade represents a 3.30% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
TriMas Stock Performance
Shares of TriMas stock opened at $25.65 on Thursday. The firm has a 50 day simple moving average of $22.98 and a 200 day simple moving average of $24.06. The firm has a market cap of $1.04 billion, a P/E ratio of 40.08 and a beta of 0.58. TriMas Co. has a fifty-two week low of $19.33 and a fifty-two week high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.
TriMas (NASDAQ:TRS – Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. During the same period in the prior year, the business posted $0.37 earnings per share. TriMas’s revenue was up 6.4% compared to the same quarter last year. Sell-side analysts predict that TriMas Co. will post 1.69 earnings per share for the current fiscal year.
TriMas Dividend Announcement
Wall Street Analyst Weigh In
Separately, BWS Financial reaffirmed a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Wednesday, April 30th.
Read Our Latest Research Report on TRS
Institutional Investors Weigh In On TriMas
Institutional investors have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in TriMas by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company’s stock valued at $568,000 after buying an additional 834 shares during the period. Sterling Capital Management LLC increased its stake in shares of TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company’s stock valued at $32,000 after acquiring an additional 1,158 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of TriMas by 3.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after acquiring an additional 1,227 shares during the period. MetLife Investment Management LLC boosted its stake in TriMas by 5.9% during the 4th quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company’s stock worth $610,000 after acquiring an additional 1,378 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in TriMas by 0.7% during the 1st quarter. Bank of New York Mellon Corp now owns 247,761 shares of the industrial products company’s stock worth $5,805,000 after acquiring an additional 1,664 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Recommended Stories
- Five stocks we like better than TriMas
- Investing In Automotive Stocks
- Renaissance Hedge Fund’s Biggest Q1 Buys Revealed
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 5 Reasons You Will Be Glad You Bought Target in 2025
- 3 REITs to Buy and Hold for the Long Term
- Moderna Stock Looks Ripe for a Short Squeeze
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.